Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 3.655
+0.040 (1.11%)
At close: Jan 30, 2026
Idorsia Market Cap
Idorsia has a market cap or net worth of 916.44 million as of January 30, 2026. Its market cap has increased by 556.20% in one year.
Market Cap
916.44M
Enterprise Value
2.11B
Revenue
232.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.66
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 916.44M, a decrease of -43.64%. That is a compound annual growth rate of -6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 916.44M | -13.77% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Basilea Pharmaceutica AG | 674.62M |
| Newron Pharmaceuticals | 394.29M |
| Santhera Pharmaceuticals Holding AG | 177.93M |
| BioVersys AG | 140.94M |
| Xlife Sciences AG | 127.46M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.83M |